Powerful System Stirs 3 Reactions in Parallel    
The DrySyn Vortex overhead stirrer system from Asynt.

Laboratory products

Powerful System Stirs 3 Reactions in Parallel    

12 Aug, 2022

Published over 3 years ago. See the latest and most current information on Laboratory products.

Incorporating an energy efficient drive mechanism, the compact DrySyn Vortex overhead stirrer system from Asynt delivers effective overhead stirring to three round bottom flasks (100 mL to 500 mL) in parallel with stirring from 50 to 500 rpm.

Suitable for reaction temperatures up to 200°C, the DrySyn Vortex is the perfect process development tool to efficiently, and safely, drive three stirrer shafts with one overhead stirrer. The compact footprint of the DrySyn Vortex is designed to operate on a single standard hotplate.

The powerful DrySyn Vortex features a reduction drive proven to work even with higher viscosity substances, where magnetic stirring is not strong enough or where materials could be damaged by the grinding effect of a magnetic stirring bar. Users may also use a smaller overhead stirrer.

An optional adaptation to the DrySyn Vortex has been developed specifically to cater for the requirements of scientists who need to test in parallel in beakers. The DrySyn Vortex blend, able to hold three 600 mL beakers, will be of interest to blending and formulation scientists in the oil, cosmetics, cleansing and hygiene industries.

More information online

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Valmet to deliver automation system for CO₂ liquefaction plant advancing Finland's green transition
Explore more Arrow
Petro Online
Why more industries are moving beyond fixed oil change schedules
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow